New distribution agreement to provide greater choice in polymers

Borealis, a major provider of advanced and circular polyolefin solutions, has selected IMCD as its new European distributor of its dedicated grade range of Bormed polyolefins for healthcare. 

The distribution agreement, which covers most of Europe (with the exception of Switzerland and the South-Eastern countries) and takes effect as of 1 October 2021, applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices.¹

IMCD's strong presence in medical and healthcare applications has made it the ideal partner for Borealis customers in Europe thanks to its broad technical expertise and dedicated medical application team. The extensive IMCD polymers range complements the Borealis Bormed portfolio, opening a range of new possibilities.

“We are pleased to have found in IMCD a partner sharing the core Bormed values of service, commitment and conformance,” said John Webster, Borealis Head of Sales Advanced Products. “What also unites us is our dedication to providing best-in-class service to all of our healthcare customers, both direct and indirect, by way of more intensive and efficient value chain collaboration. We are confident that this new agreement will significantly boost our presence in this increasingly important sector.”

In line with its commitment to service as the foundation of successful industry co-operation, Borealis and IMCD will together ensure a seamless distribution transition for their customers, who can continue to count on security of supply as well as the ready assistance of experienced technical and sales teams.

Note

1. The distribution agreement covers most of Europe, with the exception of Switzerland, Albania, Bulgaria, Romania, Macedonia, Slovenia, Hungary, Bosnia-Herzegovina, Croatia, Kosovo, Montenegro and Serbia.